Cancer Imaging (Jun 2022)

Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma

  • Valentina Kouwenberg,
  • Lusien van Santwijk,
  • Frederick J. A. Meijer,
  • Dylan Henssen

DOI
https://doi.org/10.1186/s40644-022-00466-2
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 11

Abstract

Read online

Highlights • DSC-MR perfusion imaging measurements in non-treated glioma is highly reliable between readers, even readers with little experience. • DSC-MR perfusion imaging measurements in treated glioma is show to be inconsistent between readers. • When using DSC-MR perfusion imaging as a quantitative surveillance tool for the recurrence of glioma after treatment, double-reading should be preferred.

Keywords